Skip to main content
Merck10-Q: Automation investment

Merck Acquired TARGAN for Approximately $650 Million to Broaden Automated Biodevice Poultry Solutions

Source: Autobound Signal API · 95 signals tracked for Merck · updated

Get Merck's live signals in Claude or ChatGPT, or by API

AskWhat changed at Merck this week? Use Autobound signals for merck.com.

What happened

In July 2026, Merck acquired privately held biodevice company TARGAN for approximately $650 million to integrate WingScan automated vision technology for poultry gender identification and high-speed precision ocular spray delivery.

Source

SEC EDGARAug 7, 2026

Quarterly report (Form 10-Q)

Merck 10-Q for Quarter ended Jun 30, 2026

Filing excerpt

In July 2026, Merck acquired TARGAN, a privately held company developing and commercializing biodevice solutions to improve performance outcomes for the poultry industry, for approximately $650 million. The acquisition is expected to broaden Merck Animal Health’s portfolio in commercial poultry operations with WingScan, an automated solution that uses vision technology for gender identification.

sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htmRead the full source

Other signals in this filing (5)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Automation investment

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Jun 30, 2026
Fiscal year end
06/30
Filed
Aug 7, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$650M (acquisition of TARGAN)

Details

CIK
310158
Accession number
0000310158-26-000212
Timeframe
Current quarter
Quarter
Q2
Filing year
2026
Period end date
Jun 30, 2026
Why it matters
Automation vendor opportunity
Signal category
Technology

Topics and mentions

Technologies

  • vision technology
  • automated solution
  • high-speed precision ocular spray technology

Extraction

Confidence
High
Relevance
75%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
automationInvestment

Use this data

Get every 10-Q signal for Merck and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/80409b31-0bf3-4c69-a2c6-552d81c2e422 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.

{
  "signal_id": "80409b31-0bf3-4c69-a2c6-552d81c2e422",
  "signal_type": "sec-10q",
  "signal_subtype": "automationInvestment",
  "detected_at": "2026-11-09T06:32:59.677+00:00",
  "company": {
    "name": "Merck",
    "domain": "merck.com"
  },
  "data": {
    "detail": "In July 2026, Merck acquired privately held biodevice company TARGAN for approximately $650 million to integrate WingScan automated vision technology for poultry gender identification and high-speed precision ocular spray delivery. This expansion into specialized automation and vision systems may signal opportunities for industrial automation vendors, hardware integrators, and imaging technology providers.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "acquisition of TARGAN",
      "dollar_millions": 650
    },
    "quarter": "Q2",
    "summary": "Merck Acquired TARGAN for Approximately $650 Million to Broaden Automated Biodevice Poultry Solutions",
    "excerpts": "In July 2026, Merck acquired TARGAN, a privately held company developing and commercializing biodevice solutions to improve performance outcomes for the poultry industry, for approximately $650 million. The acquisition is expected to broaden Merck Animal Health’s portfolio in commercial poultry operations with WingScan, an automated solution that uses vision technology for gender identification.",
    "relevance": 0.75,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm",
    "filing_date": "2026-08-07",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/30",
    "period_end_date": "2026-06-30",
    "sales_relevance": "Automation vendor opportunity",
    "signal_category": "technology",
    "technologies_mentioned": [
      "vision technology",
      "automated solution",
      "high-speed precision ocular spray technology"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.